Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: A cross-sectional study

BMJ Open

Volumn 3, Issue 8, 2013, Pages

  Joffres, Michel ^a   Falaschetti, Emanuela ^b   Gillespie, Cathleen ^c   Robitaille, Cynthia ^d   Loustalot, Fleetwood ^c   Poulter, Neil ^b   McAlister, Finlay A ^e   Johansen, Helen ^f   Baclic, Oliver ^d   Campbell, Norm ^g  

^a SIMON FRASER UNIVERSITY   (Canada)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^e UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AWARENESS; CANADA; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREHYPERTENSION; PREVALENCE; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM; UNITED STATES;

EID: 84885353802     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003423     Document Type: Article

References (41)

1. WHO. World Health Organization, World Health Statistics 2012. Geneva: World Health Organization, 2012. http://www.who.int/gho/publications/world- health-statistics/2012/en/index.html (accessed Apr 2013).
2. Kearney PM, Whelton M, Reynolds K., et al Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-23. (Pubitemid 40138015)
3. Gaziano TA, Bitton A, Anand S., et al The global cost of nonoptimal blood pressure. J Hypertens 2009;27:1472-7.
4. Lewington S, Clarke R, Qizilbash N., et al Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13. (Pubitemid 35472129)
5. Law MR, Morris JK, Wald NJ Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665.
6. Chobanian AV, Bakris GL, Black H.R., et al National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72. (Pubitemid 37430158)
7. Kearney PM, Whelton M, Reynolds K., et al Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004;22:11-19. (Pubitemid 38293521)
8. National Heart Lung and Blood Institute. National High Blood Pressure Education Program. http://www.nhlbi.nih.gov/about/nhbpep/index.htm (accessed Apr 2013).
9. McAlister FA. The Canadian Hypertension Education Program (CHEP)-a unique Canadian initiative. Can J Cardiol 2006;22:559-64.
10. National Institute for Health and Clinical Excellence. Hypertension: clinical management of primary hypertension in adults. Clinical guidelines, CG127-Issued: August 2011. http://guidance.nice.org.uk/CG127 (accessed Apr 2013).
11. CDC. National Health and Nutrition Examination Survey Data. Hyattsville, MD: US Department of Health and Human Services, CDC, 2010. http://www.cdc.gov/ nchs/nhanes/about-nhanes.htm (accessed Apr 2013).
12. Craig R, Mindell J, eds. Health Survey for England 2006. London, UK: The Information Centre, 2008.
13. The Canadian Health Measures Survey: Rationale background and overview. http://www.statcan.gc.ca/pub/82-003-s/82-003-s2007000-eng.htm (accessed Apr 2013).
14. Causes of Death 2008 Summary Tables, May 2011. Health statistics and informatics Department, World Health Organization, Geneva, Switzerland. http://www.who.int/evidence/bod (accessed Apr 2013).
15. Mortality Statistics Newport: Office for National Statistics. Deaths registered in 2006. Review of the Registrar General on deaths in England and Wales, 2006. http://www.ons.gov.uk/ons/rel/vsob1/mortality-statistics-deaths- registered-in-england-and-wales-series-dr-/2006/data-tables-2006.zip (accessed Apr 2013).
16. Wilkins K, Campbell NRC, Joffres MR, et al Blood pressure in Canadian adults. Health Rep 2010;21:1-10.
17. Falaschetti E, Chaudhury M, Mindell J., et al Continued improvement in hypertension management in England: results from the health survey for England 2006. Hypertension 2009;53:480-6.
18. Egan BM, Zhao Y, Axon RN US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010;303:2043-50.
19. Centers for Disease Control and Prevention. Vital signs: awareness and treatment of uncontrolled hypertension among adults-United States, 2003-2010 Morbidity and Mortality Weekly Report 2012;61:703-9.
20. McAlister FA, Wilkins K, Joffres M., et al Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 2011;183:1007-13.
21. Martinson ML, Teitler JO, Reichman NE Health across the lifespan in the United States and England. Am J Epidemiol 2011;173: 858-65.
22. Cheng S, Xanthakis V, Sullivan L.M., et al Blood pressure tracking over the adult life course: patterns and correlates in the Framingham heart study. Hypertension 2012;60:1393-9.
23. Lien N, Henriksen HB, Nymoen L.L., et al Availability of data assessing the prevalence and trends of overweight and obesity among European adolescents. Public Health Nutr 2010;13:1680-7.
24. United States Preventive Services Task Force. Recommendations. http://www.uspreventiveservicestaskforce.org/recommendations.htm (accessed Apr 2013).
25. Centers for Disease Control and Prevention. Million Hearts: strategies to reduce the prevalence of leading cardiovascular disease risk factors, United States, 2011. Morbidity and Mortality Weekly Report. 2011;60:1248-51.
26. Centers for Disease Control and Prevention. Sodium Reduction in Communities Program. http://www.cdc.gov/dhdsp/programs/sodium-reduction.htm (accessed Apr 2013).
27. Centers for Disease Control and Prevention. Community Transformation Grant Program. http://www.cdc.gov/communitytransformation/ (accessed Apr 2013).
28. US Department of Health and Human Services, US Department of Agriculture. Dietary Guidelines for Americans, 2010. 7th edn. Washington, DC, 2011.
29. Institute of Medicine. A population-based policy and systems change approach to prevent and control hypertension. Washington, DC: National Academy of Sciences, 2010.
30. National Institute for Health and Clinical Excellence. Hypertension: clinical management of primary hypertension in adults. Clinical guidelines, CG127. http://guidance.nice.org.uk/CG127 (accessed Apr 2013).
31. National Institute for Health and Clinical Excellence. Prevention of cardiovascular disease at the population level. Public health guidance, PH2; 2010. http://guidance.nice.org.uk/PH25 (accessed Apr 2013).
32. Doran T, Fullwood C, Gravelle H., et al Pay-for-performance programs in family practices in the United Kingdom. N Engl J Med 2006;355:375-84. (Pubitemid 44127540)
33. Serumaga B, Ross-Degnan D, Avery A.J., et al Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study. BMJ 2011;342: d108.
34. Campbell N, Young E, Drouin D., et al A framework for discussion on how to improve prevention, management and control of hypertension in Canada. Can J Cardiol 2012;28:262-9.
35. McAlister FA, Feldman RD, Wyard K, et al CHEP Outcomes Research Task Force. The impact of the Canadian Hypertension Education Programme in its first decade. Eur Heart J 2009;30:1434-9.
36. National Institute for Health and Clinical Excellence. Hypertension: management of hypertension in adults in primary care. Clinical guidelines, CG34; 2006. http://www.nice.org.uk/nicemedia/pdf/CG034NICEguideline.pdf (accessed Apr 2013).
37. Joffres MR, Campbell NR, Manns B, et al Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in Canada. Can J Cardiol 2007;23:437-43. (Pubitemid 46977999)
38. Karppanen H, Mervaala E. Sodium intake and hypertension. Prog Cardiovasc Dis 2006;49:59-75. (Pubitemid 44540370)
39. Myers MG, McInnis NH, Fodor G.J., et al Comparison between an automated and manual sphygmomanometer in a population survey. Am J Hypertens 2008;21:280-3. (Pubitemid 351323269)
40. Pereira M, Lunet N, Azevedo A., et al Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens 2009;27:963-75.
41. Danaei G, Finucane MM, Lin J.K., et al Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Pressure). National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 2011;377:568-77.